{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:40:24Z","timestamp":1756294824993,"version":"3.44.0"},"reference-count":18,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,4,17]]},"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>We present a case of a pregnant woman with chronic immune thrombocytopenic purpura and chronic hypertension who developed pre-eclampsia with severe features warranting delivery. Her overall clinical picture and liver enzymes improved in the immediate postpartum period, however, aggressively progressing thrombocytopenia posed a diagnostic dilemma to the interdisciplinary care team. After failing to respond to first-line therapies including high-dose corticosteroids and intravenous immunoglobulin, she was successfully managed with a trial of the thrombopoietin receptor agonist, Romiplostim.<\/jats:p>","DOI":"10.1136\/bcr-2020-234335","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T05:40:17Z","timestamp":1589866817000},"page":"e234335","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Romiplostim for management of refractory immune thrombocytopenic purpura in the immediate postpartum period"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct00116688","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0135-4655","authenticated-orcid":false,"given":"Ariana","family":"Patras","sequence":"first","affiliation":[{"name":"Department of OB\/GYN, Trinity Health of New England, Hartford, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinaldo","family":"Figueroa","sequence":"additional","affiliation":[{"name":"Department of OB\/GYN, Trinity Health of New England, Hartford, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit P","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Trinity Health of New England, Mercy Medical Center, Springfield, Massachusetts, USA"},{"name":"Department of Nephrology, Baystate Medical Center, Springfield, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichchha","family":"Madan","sequence":"additional","affiliation":[{"name":"Department of OB\/GYN, Trinity Health of New England, Hartford, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"2025082704093377000_13.5.e234335.1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181b48ef5"},{"key":"2025082704093377000_13.5.e234335.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292005"},{"key":"2025082704093377000_13.5.e234335.3","first-page":"795","article-title":"The differential diagnosis of thrombocytopenia in pregnancy","volume":"112","author":"Bergmann","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"2025082704093377000_13.5.e234335.4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.preghy.2019.08.004","article-title":"Placenta derived factors involved in the pathogenesis of the liver in the syndrome of haemolysis, elevated liver enzymes and low platelets (HELLP): a review","volume":"18","author":"van Lieshout","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"2025082704093377000_13.5.e234335.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-448944"},{"key":"2025082704093377000_13.5.e234335.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-162503"},{"key":"2025082704093377000_13.5.e234335.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-302984"},{"key":"2025082704093377000_13.5.e234335.8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.autrev.2014.01.026","article-title":"Diagnosis and classification of immune-mediated thrombocytopenia","volume":"13","author":"Lo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2025082704093377000_13.5.e234335.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-225565"},{"key":"2025082704093377000_13.5.e234335.10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00295"},{"key":"2025082704093377000_13.5.e234335.11","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719841735","article-title":"Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia","volume":"10","author":"Al-Samkari","year":"2019","journal-title":"Ther Adv Hematol"},{"key":"2025082704093377000_13.5.e234335.12","first-page":"212","article-title":"Thrombopoietin receptor agonists: eltrombopag and Romiplostim for the treatment of chronic immune thrombocytopenia purpura","volume":"23","author":"Atkinson","year":"2019","journal-title":"Clin J Oncol Nurs"},{"key":"2025082704093377000_13.5.e234335.13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/ejh.13319","article-title":"Autoimmune thrombocytopenia: current treatment options in adults with a focus on novel drugs","volume":"103","author":"Witkowski","year":"2019","journal-title":"Eur J Haematol"},{"key":"2025082704093377000_13.5.e234335.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1855-5"},{"key":"2025082704093377000_13.5.e234335.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-150078"},{"key":"2025082704093377000_13.5.e234335.16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1753495X18773960","article-title":"Use of romiplostim in pregnancy for refractory idiopathic thrombocytopenic purpura: two case reports with maternal and fetal outcomes and literature review","volume":"13","author":"Chua","year":"2020","journal-title":"Obstet Med"},{"key":"2025082704093377000_13.5.e234335.17","unstructured":"Briggs GG , Freeman RK , Towers CV . Forinash ab Briggs drugs in pregnancy and lactation. 11th edn. Philadelphia: Wolters Kluwer, 2017."},{"key":"2025082704093377000_13.5.e234335.18","unstructured":"Amgen Inc . Nplate (romiplostim) [prescribing information. Thousand Oaks: Calif:Amgen Inc, 2008."}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-234335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:09:44Z","timestamp":1756292984000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-234335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,18]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/bcr-2020-234335"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-234335","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}